Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses
- 4 August 2014
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 23 (8) , 585-590
Abstract
Heat shock protein 90 (Hsp90) inhibition blocks T‐cell‐linked inflammatory disease pathways and exhibits therapeutic activity in autoimmune disease mouse models, including the blistering disease epidermolysis bullosa acquisita. Although we previously showed that preformed autoreactive plasma cells do not seem to be directly affected by anti‐Hsp90 treatment, immunomodulatory effects of Hsp90 inhibition on (auto‐)antibody responses are not yet fully understood. In this study, the Hsp90 blocker 17‐DMAG inhibited proliferation of activated total B cells and their IgG secretion in cultures of human peripheral B cells from healthy subjects, but IgG production was no longer affected when these activated B cells were allowed to differentiate prior to a deferred application of the inhibitor. 17‐DMAG treatment was associated with induction of nuclear and cytoplasmic heat shock factor 1 and Hsp70 in stimulated human B cells, respectively. Type VII collagen (epidermolysis bullosa acquisita)‐immunized mice early treated with 17‐DMAG had reduced total B cells in spleens, a relative increase in splenic regulatory B cell fractions, higher serum IL‐10 concentrations, and lower levels of circulating autoantibodies (paralleled by less pronounced disease induction) compared with vehicle‐treated immunized mice. Autoantibody production was blunted in isolated and autoantigen‐restimulated lymph node cells from immunized mice by either 17‐DMAG or purified autologous splenic regulatory B cells. Thus, in addition to the previously described T cell inhibitory effects of Hsp90 blockade, this treatment potently modulates humoral immune responses at the B cell level, further supporting the introduction of Hsp90 inhibitors into the clinical setting for treatment of autoantibody‐mediated disorders.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG KA 3438/1-1)
- Deutsche Forschungsgemeinschaft (EXC 306/2)
This publication has 28 references indexed in Scilit:
- Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg functionMucosal Immunology, 2013
- Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients with Bullous PemphigoidPLOS ONE, 2013
- Regulatory cell subsets in the control of autoantibody production related to systemic autoimmunityAnnals of the Rheumatic Diseases, 2013
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactionsNature, 2012
- Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory CellsMolecular and Cellular Biology, 2011
- Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cellsBlood, 2011
- An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitorsBiomarkers, 2009
- Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effectsCell Stress and Chaperones, 2009
- Roles of heat-shock proteins in innate and adaptive immunityNature Reviews Immunology, 2002
- Identification of the Skin Basement-Membrane Autoantigen in Epidermolysis Bullosa AcquisitaNew England Journal of Medicine, 1984